Effects of a Genetic Variation in the PSA Gene on Prostate Cancer Risk
Author Information
Author(s): Jesser C, Mucci L, Farmer D, Moon C, Li H, Gaziano J M, Stampfer M, Ma J, Kantoff P
Primary Institution: Harvard School of Public Health
Hypothesis
Does the G/A polymorphism in the PSA gene affect prostate cancer risk and survival?
Conclusion
The study found no significant association between the rs266882 polymorphism in the PSA gene and prostate cancer risk or survival.
Supporting Evidence
- The study included a large sample size of 500 cases and 676 controls.
- Conditional logistic regression was used to analyze the data.
- No significant associations were found between the rs266882 genotype and prostate cancer risk.
- Meta-analysis of 12 studies also showed no overall effect of the variant on prostate cancer risk.
Takeaway
This study looked at a specific gene change to see if it affects prostate cancer risk, but it found that it doesn't seem to make a difference.
Methodology
A nested case-control study was conducted with 500 prostate cancer cases and 676 matched controls, analyzing genetic data and PSA levels.
Potential Biases
Potential for population stratification due to the focus on a specific ethnic group.
Limitations
The study was limited to white men, which may affect the generalizability of the findings.
Participant Demographics
500 white male prostate cancer cases and 676 matched controls, aged 40-84.
Statistical Information
Confidence Interval
95% CI: 0.88–1.67 for risk, 95% CI: 0.56–1.58 for survival
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website